Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,915 Cr
up ₹277 Cr vs Nov 2024
- Stocks held
- 36
- up 1 vs Nov 2024
- Top 10 weight
- 61.0%
- of the portfolio in its ten largest
- Cash & debt
- 1.9%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 10
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In December 2024 it disclosed 36 stocks worth ₹8,915 Cr, up ₹277 Cr from Nov 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.9%), Divi's Laboratories Limited (9.2%), Lupin Limited (8.5%); the ten largest together made up 61.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.8% of its equity. Cash and debt stood at 1.9%. Compared with Nov 2024 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
31%
Holds more stocks than 31% of peers
Cash
29%
Holds more cash than 29% of peers
Holdings in December 2024
Download CSVEvery line the fund disclosed, with the change against Nov 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.87%
- Δ weight
- up 0.36 pts
- Value
- ₹1,237 Cr
- Δ value
- up ₹69.1 Cr
- Status
- Added
- Weight
- 9.24%
- Δ weight
- down 0.41 pts
- Value
- ₹824 Cr
- Δ value
- down ₹10 Cr
- Status
- Trimmed
- Weight
- 8.47%
- Δ weight
- up 0.86 pts
- Value
- ₹755 Cr
- Δ value
- up ₹97.7 Cr
- Status
- Added
- Weight
- 5.70%
- Δ weight
- up 0.61 pts
- Value
- ₹508 Cr
- Δ value
- up ₹68.2 Cr
- Status
- Added
- Weight
- 5.32%
- Δ weight
- down 0.19 pts
- Value
- ₹474 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Held
- Weight
- 5.31%
- Δ weight
- up 0.18 pts
- Value
- ₹473 Cr
- Δ value
- up ₹30.3 Cr
- Status
- Added
- Weight
- 3.59%
- Δ weight
- down 0.50 pts
- Value
- ₹320 Cr
- Δ value
- down ₹33.2 Cr
- Status
- Trimmed
- Weight
- 3.32%
- Δ weight
- up 0.09 pts
- Value
- ₹296 Cr
- Δ value
- up ₹17.2 Cr
- Status
- Added
- Weight
- 3.16%
- Δ weight
- down 0.20 pts
- Value
- ₹281 Cr
- Δ value
- down ₹8.7 Cr
- Status
- Trimmed
- Weight
- 2.99%
- Δ weight
- down 0.02 pts
- Value
- ₹267 Cr
- Δ value
- up ₹6.2 Cr
- Status
- Added
- Weight
- 2.88%
- Δ weight
- up 0.11 pts
- Value
- ₹257 Cr
- Δ value
- up ₹17.4 Cr
- Status
- Added
- Weight
- 2.65%
- Δ weight
- up 0.08 pts
- Value
- ₹236 Cr
- Δ value
- up ₹13.9 Cr
- Status
- Added
- Weight
- 2.55%
- Δ weight
- up 0.06 pts
- Value
- ₹227 Cr
- Δ value
- up ₹12.2 Cr
- Status
- Added
- Weight
- 2.42%
- Δ weight
- down 0.25 pts
- Value
- ₹216 Cr
- Δ value
- down ₹14.5 Cr
- Status
- Trimmed
- Weight
- 2.18%
- Δ weight
- down 0.06 pts
- Value
- ₹194 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 2.14%
- Δ weight
- down 0.06 pts
- Value
- ₹191 Cr
- Δ value
- up ₹92 L
- Status
- Held
- Weight
- 2.10%
- Δ weight
- down 0.25 pts
- Value
- ₹188 Cr
- Δ value
- down ₹16 Cr
- Status
- Trimmed
- Weight
- 1.90%
- Δ weight
- down 0.04 pts
- Value
- ₹169 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 1.89%
- Δ weight
- down 0.07 pts
- Value
- ₹168 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.86%
- Δ weight
- down 1.21 pts
- Value
- ₹166 Cr
- Δ value
- down ₹99.6 Cr
- Status
- Trimmed
- Weight
- 1.86%
- Δ weight
- up 0.10 pts
- Value
- ₹166 Cr
- Δ value
- up ₹13.9 Cr
- Status
- Added
- Weight
- 1.81%
- Δ weight
- down 0.24 pts
- Value
- ₹161 Cr
- Δ value
- down ₹15.6 Cr
- Status
- Trimmed
- Weight
- 1.75%
- Δ weight
- down 0.06 pts
- Value
- ₹156 Cr
- Δ value
- down ₹24 L
- Status
- Held
- Weight
- 1.58%
- Δ weight
- down 0.12 pts
- Value
- ₹141 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Weight
- 1.26%
- Δ weight
- up 0.05 pts
- Value
- ₹113 Cr
- Δ value
- up ₹8.1 Cr
- Status
- Added
- Weight
- 1.21%
- Δ weight
- up 0.80 pts
- Value
- ₹108 Cr
- Δ value
- up ₹72.5 Cr
- Status
- Added
- Weight
- 1.18%
- Δ weight
- down 0.01 pts
- Value
- ₹105 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 1.08%
- Δ weight
- down 0.14 pts
- Value
- ₹96.6 Cr
- Δ value
- down ₹9.3 Cr
- Status
- Trimmed
- Weight
- 0.97%
- Δ weight
- down 0.03 pts
- Value
- ₹86.7 Cr
- Δ value
- down ₹7 L
- Status
- Held
- Weight
- 0.68%
- Δ weight
- down 0.01 pts
- Value
- ₹61 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 0.53%
- Δ weight
- up 0.53 pts
- Value
- ₹47.3 Cr
- Δ value
- up ₹47.3 Cr
- Status
- New
- Weight
- 0.53%
- Δ weight
- up 0.04 pts
- Value
- ₹46.8 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 0.49%
- Δ weight
- down 0.03 pts
- Value
- ₹44 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 0.49%
- Δ weight
- up 0.01 pts
- Value
- ₹43.4 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 0.45%
- Δ weight
- up 0.03 pts
- Value
- ₹40.4 Cr
- Δ value
- up ₹3.6 Cr
- Status
- Added
- Weight
- 0.31%
- Δ weight
- down 0.01 pts
- Value
- ₹27.6 Cr
- Δ value
- up ₹39 L
- Status
- Added
- Weight
- 0.28%
- Δ weight
- up <0.01 pts
- Value
- ₹24.7 Cr
- Δ value
- up ₹93 L
- Status
- Added
What changed, Nov 2024 to Dec 2024
New New positions (1)
- Sai Life Sciences Limited0.5% · ₹47.3 Cr
Exited Exited (0)
None.
Added Biggest additions
- Lupin Limitedup ₹97.7 Cr (+0.86% pts)
- Suraksha Diagnostic Limitedup ₹72.5 Cr (+0.80% pts)
- Sun Pharmaceutical Industries Limitedup ₹69.1 Cr (+0.36% pts)
- Dr. Reddy's Laboratories Limitedup ₹68.2 Cr (+0.61% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.1 pts), and fell most in Healthcare Services (−0.2 pts).
- Pharmaceuticals & Biotechnology76.7% → 76.8%+0.1 pts
- Healthcare Services19.3% → 19.1%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2021 | Dec 2023 | Jun 2024 | Sep 2024 | Nov 2024 | Dec 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.5% | 77.0% | 78.7% | 79.0% | 76.7% | 76.8% |
| Healthcare Services | 21.0% | 18.1% | 17.6% | 17.8% | 19.3% | 19.1% |
| Retailing | — | 3.6% | 2.9% | 2.4% | 3.3% | 3.4% |
| Pharmaceuticals | 2.0% | 1.1% | 0.8% | 0.8% | 0.7% | 0.7% |
Allocation in Dec 2024change vs Nov 2024
- Pharmaceuticals & Biotechnology (24)76.8%▲ 0.1 pts
- Healthcare Services (10)19.1%▼ 0.2 pts
- Retailing (1)3.4%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Dec 2024
1.9%
▼ 1.2 pts vs Nov 2024
- Cash alone
- 1.9%
- cash and net receivables
- A year earlier
- 1.5%
- Dec 2023 · now ▲ 0.4 pts
- Last 12 months
- 0.6% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.